Active ingredients
Pharmacological Group
Used in the treatment of
- T39.9 Poisoning, nonopioid analgesic, antipyretic and antirheumatic, unspecified
- R58 Haemorrhage, not elsewhere classified
- R31 Unspecified haematuria
- R04.8 Haemorrhage from other sites in respiratory passages
- R04.0 Epistaxis
- N92.1 Excessive and frequent menstruation with irregular cycle
- N92.0 Excessive and frequent menstruation with regular cycle
- K92.2 Gastrointestinal haemorrhage, unspecified
- I78.8 Other diseases of capillaries
- I77.6 Arteritis, unspecified
- H44.8 Other disorders of globe
- H36.0 Diabetic retinopathy (E10-E14+ with common fourth character .3)
- H35.6 Retinal haemorrhage
- D69.9 Haemorrhagic condition, unspecified
- D69.3 Idiopathic thrombocytopenic purpura
- D69.1 Qualitative platelet defects
- D68.9 Coagulation defect, unspecified
- D68.0 Von Willebrand's disease
- T81.0 Haemorrhage and haematoma complicating a procedure, not elsewhere classified
- Z01.2 Dental examination
- Z40 Prophylactic surgery
- Z100* CHAPTER XXII Surgical practice
- I62.9 Intracranial haemorrhage (nontraumatic), unspecified
- P52.9 Intracranial (nontraumatic) haemorrhage of fetus and newborn, unspecified
- H35 Other retinal disorders
- D65-D69 Blood clotting disorders, purpura and other hemorrhagic conditions
- Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
- D68.3 Haemorrhagic disorder due to circulating anticoagulants
- I62 Other nontraumatic intracranial haemorrhage
- P10.9 Unspecified intracranial laceration and haemorrhage due to birth injury
- P52 Intracranial nontraumatic haemorrhage of fetus and newborn